PRTN3 and rheumatoid arthritis: The distribution of ADA titers at baseline and 52 weeks were shown in Fig. 1B. One case with a particularly high titer of ADA was a male patient with a 12-year history of RA who had an ACPA exceeding 400 U/ml; however, his disease activity was suppressed to the point of remission during the observation period.